All Rankings

Recently Funded Biotech Companies in the US 2026 (Last 180 Days)

Private biotechnology and genomics companies headquartered in the United States whose latest recorded funding round was announced in the last 180 days, newest first.

Known total funding for 99 of 100 ranked companies: $18.7B.

Showing top 100 matching companies · Ranked by most recent funding

Use company data through the API.
Example request
curl "https://indexed.vc/api/v1/companies?industries=Biotech,Genomics&countries=United+States&fundedAfter=2026-05-23&operatingStatus=active&sort=last_funding_date&order=desc&limit=100" -H "X-API-Key: YOUR_API_KEY"

The API can include out-of-scope company records; this core research list excludes them.

The API has no company type filter, so public companies can appear; this list counts private companies only.

The API cannot leave out companies whose latest round is a grant; this list does.

Data from Indexed.vcUpdated

Methodology: up to 100 active companies matching this list's filters are ordered by most recent announced round. Companies whose latest round is one of: Grant are excluded. Totals include recorded grants and other qualifying funding, not just equity. Open a company profile for its funding summary and available detail. How this data is built.

51
Celea Therapeutics

Celea advances deupirfenidone for people with serious respiratory diseases, targeting idiopathic ...

Boston, United States11–50Biotech, Healthcare
Series BTotal funding$255.0MJul 2026
52
Adjuvia Therapeutics

Mitochondrial disease therapy platform for clinical development

San Francisco, United States1–10Biotech, Healthcare
SeedTotal funding$8.0MJul 2026
53
Beeline Medicines

Beeline Medicines is a clinical-stage biotechnology company developing precision therapies for pe...

Boston, United States11–50Biotech, Healthcare
Series ATotal funding$852.6MJul 2026
54
Flare Therapeutics

Biotech startup developing precision small molecule medicines targeting transcription factors for...

Cambridge, United States11–50Biotech, Healthcare
Series CTotal funding$290.0MJun 2026
55
Xellar Biosystems

The world's first market-leading organ-on-chip platform, powered by pharmaceutical-scale engineer...

Boston, United States11–50Biotech, Life Sciences
Series ATotal funding$50.0MJun 2026
56
Lycia Therapeutics

Lycia develops LYTAC therapeutics that transport disease-causing extracellular proteins into cell...

South San Francisco, United States11–50Biotech, Healthcare
Series DTotal funding$301.6MJun 2026
57
Oblenio Bio

Clinical-stage biotech developing a tri-specific antibody targeting BCMA, CD19, and CD3 to achiev...

Cambridge, United States11–50Biotech, Healthcare
Series BTotal funding$62.0MJun 2026
58
Remix Therapeutics

Clinical-stage biotechnology company developing small molecule therapies to modulate RNA processing.

Watertown, United States51–200Biotech
Venture RoundTotal funding$311.0MJun 2026
59
Ollin Biosciences

Clinical-stage biopharmaceutical company dedicated to developing best-in-disease therapies for vi...

Austin, United States11–50Biotech, Healthcare
Series BTotal funding$430.0MJun 2026
60
RQ Bio

Biotechnology company advancing precision medicine and drug development.

London, United States11–50Biotech, Healthcare
Venture RoundTotal funding$115.0MJun 2026
61
Osanni Bio

San Francisco therapeutics company using a biodesign-driven innovation engine to discover ophthal...

San Francisco, United States11–50Biotech, Healthcare
Venture RoundTotal funding$230.0MJun 2026
62
Rapalogix Health

Rapalogix Health develops therapeutics targeting TORC1 dysregulation in dermatologic conditions a...

New York, United States1–10Biotech, Healthcare
Series ATotal funding$20.0MJun 2026
63
Serapha Bio

Serapha Bio develops SERP-01, a proprietary in vivo base editing program in a Phase 1/2 clinical ...

San Diego, United States1–10Biotech, Healthcare
Series ATotal funding$138.0MJun 2026
64
TRIMTECH Therapeutics

Develops TRIMTAC and TRIMGLUE small-molecule degraders that selectively degrade disease-causing p...

Cambridge, United States1–10Biotech
SeedTotal funding$45.0MJun 2026
65
DropGenie

DropGenie develops patented chips that miniaturize and parallelize cell engineering reactions, en...

Cambridge, United States1–10Biotech, Drug Discovery
SeedJun 2026
66
Nura Bio

Clinical-stage biotech developing neuroprotective SARM1 inhibitor therapies for ALS and other neu...

South San Francisco, United States11–50Biotech, Healthcare
Series BTotal funding$143.8MJun 2026
67
cAMPfield Therapeutics

Clinical-stage biopharmaceutical company developing prifemilast, an oral PDE4B-selective inhibito...

San Diego, United States1–10Biotech, Healthcare
Series ATotal funding$180.0MJun 2026
68
Cour

COUR develops targeted therapies for autoimmune diseases, using an antigen-specific approach to a...

Evanston, United States51–200Biotech, Healthcare
Series BTotal funding$185.0MJun 2026
69
Portal Biotechnologies

Portal develops a universal cell engineering platform for research, drug discovery, and accessibl...

Watertown, United States11–50Biotech, Healthcare
Venture RoundTotal funding$21.0MJun 2026
70
Clair Health

Clair Health develops a noninvasive wearable that gives women continuous hormone insights while p...

San Francisco, United States1–10Biotech, Healthcare
SeedTotal funding$11.6MJun 2026
71
Spot Biosystems

Clinical-stage biopharmaceutical company developing extracellular-vesicle delivery for non-viral ...

Boston, United States11–50Biotech, Healthcare
SeedTotal funding$40.0MJun 2026
72
Triveni Bio

Clinical-stage biotech using a genetics-informed approach to develop functional antibodies for im...

Watertown, United States11–50Biotech, Healthcare
Venture RoundTotal funding$272.0MJun 2026
73
Cellares

Cellares develops and operates automated smart factories that manufacture cell therapies for biot...

South San Francisco, United States51–200Biotech, Healthcare
Series DTotal funding$939.0MJun 2026
74
NIRRIN TECHNOLOGIES INC

R&D company with 1 SBIR/STTR awards from Department of Health and Human Services.

Billerica, United States1–10Biotech, Healthcare
Venture RoundTotal funding$15.2MJun 2026
75
Radical Numerics

AI research lab building general biological intelligence models trained on DNA, RNA, and protein ...

San Francisco, United States11–50Artificial Intelligence, Biotech
SeedTotal funding$50.0MJun 2026